Investor Relations

Print page     Email page

Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, Calif. Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms responsible for hemorrhagic stroke, a significant cause of death worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. Micrus' proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells accessory devices and products used in conjunction with its microcoils.

 Cerecyte Coils in the Treatment of Intracranial Aneurysms: A Preliminary Clinical
Study

 Micrus Endovascular at the 2010 OneMedForum Conference (January 12, 2010)